Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling

Yu, Fa-Xing, Zhao, Bin, Panupinthu, Nattapon, Jewell, Jenna L., Lian, Ian, Wang, Lloyd H., Zhao, Jiagang, Yuan, Haixin +5 more·2012·Cell

Cited by (1,002)

Items 301–400 of 1,002

  1. Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness
    Nicholas Artinian, Cheri Cloninger, Brent Holmes, Angelica Benavides-Serrato, Tariq Bashir, Joseph Gera · 2015 · Journal of Biological Chemistry
  2. Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer
    Yoshie Kobayashi, Seung‐Oe Lim, Hirohito Yamaguchi · 2019 · Seminars in Cancer Biology
  3. The Hippo signal transduction network in skeletal and cardiac muscle
    Wackerhage, Henning, Del Re, Dominic P., Judson, Robert N., Sudol, Marius, Sadoshima, Junichi · 2014 · Science Signaling
  4. Multifaceted regulation and functions of YAP/TAZ in tumors (Review)
    Huirong Liu, Suya Du, Tiantian Lei, Hailian Wang, Xia He, Rongsheng Tong, Yi Wang · 2018 · Oncology Reports
  5. The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
    Mohammad Reza Zinatizadeh, Seyed Rouhollah Miri, Peyman Kheirandish Zarandi, Ghanbar Mahmoodi Chalbatani, Catarina Rapôso, Hamid Reza Mirzaei, Mohammad Esmaeil Akbari, Habibollah Mahmoodzadeh · 2019 · Genes & Diseases
  6. LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control
    Wenjian Gan, Xiaoming Dai, Xiangpeng Dai, Jun Xie, Shasha Yin, Junjie Zhu, Chen Wang, Yuchen Liu, Jianping Guo, Min Wang et al. · 2020 · Nature Cell Biology
  7. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma
    Xiangxiang Zhou, Na Chen, Hongzhi Xu, Xiaoming Zhou, Jianhong Wang, Xiaosheng Fang, Ya Zhang, Ying Li, Juan Yang, Xin Wang · 2020 · Journal of Hematology & Oncology
  8. The two sides of Hippo pathway in cancer
    Fulong Li, Kun‐Liang Guan · 2021 · Seminars in Cancer Biology
  9. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes
    Dirk Oliver Wennmann, Beate Vollenbröker, A K Eckart, Jakob Bonse, F Erdmann, Dirk Andreas Wolters, L K Schenk, Ulf Schulze, Joachim Kremerskothen, Thomas Weide et al. · 2014 · Cell Death and Disease
  10. Neuro-Mesenchymal Interaction Mediated by a β2-Adrenergic Nerve Growth Factor Feedforward Loop Promotes Colorectal Cancer Progression
    Hiroki Kobayashi, Tadashi Iida, Yosuke Ochiai, Ermanno Malagola, Xiaofei Zhi, Ruth Aroon White, Jin Qian, Feijing Wu, Quin T. Waterbury, Ru‐Hong Tu et al. · 2024 · Cancer Discovery
  11. YAP and TAZ Take Center Stage in Cancer
    Kun Zhang, Hai-Xia Qi, Zhimei Hu, Yanan Chang, Zhemin Shi, Xiaohui Han, Yawei Han, Ruixue Zhang, Zhen Zhang, Ting Chen et al. · 2015 · Biochemistry
  12. The Hippo and Wnt signalling pathways: crosstalk during neoplastic progression in gastrointestinal tissue
    Nianshuang Li, Nonghua Lü, Chuan Xie · 2019 · FEBS Journal
  13. Hippo and TGF-β interplay in the lung field
    Akira Saito, Takeshi Nagase · 2015 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  14. YAP-mediated regulation of the chondrogenic phenotype in response to matrix elasticity
    Weiliang Zhong, Ying Li, Linan Li, Weiguo Zhang, Shouyu Wang, Xifu Zheng · 2013 · Journal of Molecular Histology
  15. Endothelial Cell Mechanotransduction in the Dynamic Vascular Environment
    Frank W. Charbonier, Maedeh Zamani, Ngan Fong Huang · 2018 · Advanced Biosystems
  16. S-nitrosylation-mediated coupling of G-protein alpha-2 with CXCR5 induces Hippo/YAP-dependent diabetes-accelerated atherosclerosis
    Menglin Chao, Shanshan Luo, Chao Zhang, Xuechun Zhou, Miao Zhou, Junyan Wang, Chuiyu Kong, Jiyu Chen, Zhe Lin, Xin Tang et al. · 2021 · Nature Communications
  17. Cross-talk between Wnt/β-catenin and Hippo signaling pathways: a brief review
    Minseong Kim, Eek‐hoon Jho · 2014 · BMB Reports
  18. The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity
    Chrysiis Michaloglou, Waltraut Lehmann, Typhaine Martin, Clara Delaunay, Andreas Hueber, Louise Barys, Honglin Niu, Éric Billy, Markus Wartmann, Moriko Ito et al. · 2013 · PLoS ONE
  19. Reciprocal Crosstalk Between YAP1/Hippo Pathway and the p53 Family Proteins: Mechanisms and Outcomes in Cancer
    Nitin Raj, Rakesh Bam · 2019 · Frontiers in Cell and Developmental Biology
  20. Hippo signaling pathway and respiratory diseases
    Weifeng Tang, Min Li, Xiaoting Yangzhong, Xifeng Zhang, Anju Zu, Yunjiao Hou, Lin Li, Shibo Sun · 2022 · Cell Death Discovery
  21. ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism
    Linchong Sun, Caixia Suo, Tong Zhang, Shengqi Shen, Xuemei Gu, Shiqiao Qiu, Pinggen Zhang, Haoran Wei, Wenhao Ma, Ronghui Yan et al. · 2023 · Nature Chemical Biology
  22. Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
    Hooglugt, Aukie, van der Stoel, Miesje M., Boon, Reinier A., Huveneers, Stephan · 2021 · Frontiers in Oncology
  23. The Hippo Signaling Pathway in Drug Resistance in Cancer
    Zeng, Renya, Dong, Jixin · 2021 · Cancers
  24. The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors
    Thijs J. Hagenbeek, Joshua D. Webster, Noelyn M. Kljavin, Matthew T. Chang, Trang Pham, Ho-June Lee, Christiaan N. Klijn, Allen G. Cai, Klára Tótpál, Buvana Ravishankar et al. · 2018 · Science Signaling
  25. Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis
    Alexander Greenhough, Clare Bagley, Kate J. Heesom, David Gurevich, David Michael Gay, Mark Bond, T J Collard, C Paraskeva, Paul B. Martin, Owen James Sansom et al. · 2018 · EMBO Molecular Medicine
  26. Framework to function: mechanosensitive regulators of gene transcription
    Finch-Edmondson, Megan, Sudol, Marius · 2016 · Cellular & Molecular Biology Letters
  27. Transcription factor AP-2γ induces early Cdx2 expression and represses HIPPO signaling to specify the trophectoderm lineage
    Zubing Cao, Timothy S. Carey, Avishek Ganguly, CATHERINE A. WILSON, Soumen Paul, Jason G. Knott · 2015 · Development
  28. The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
    Reza Bayat Mokhtari, Neda Ashayeri, Leili Baghaie, Manpreet Sambi, Kosar Satari, Narges Baluch, Dmitriy A. Bosykh, Myron R. Szewczuk, Sayan Chakraborty · 2023 · Cancers
  29. Antiproliferative and Antimigratory Effects of a Novel YAP–TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking
    Sarah Ann Smith, Richard Barry Sessions, Deborah K. Shoemark, Christopher Williams, Reza Ebrahimighaei, Madeleine C. McNeill, Matthew P. Crump, Tristan R. McKay, Gemma Harris, Andrew C. Newby et al. · 2019 · Journal of Medicinal Chemistry
  30. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers
    Wei Kang · 2016 · World Journal of Gastroenterology
  31. The Hippo signaling pathway provides novel anti-cancer drug targets
    June Sung Bae, Sun Mi Kim, Ho Lee · 2016 · Oncotarget
  32. The posttranslational modifications of Hippo-YAP pathway in cancer
    Fangjie Yan, Meijia Qian, Qiaojun He, Hong Zhu, Bo Yang · 2019 · Biochimica et Biophysica Acta (BBA) - General Subjects
  33. Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration
    Wenyi Mi, Qiong Lin, Chandra Childress, Marius Sudol, Janet D. Robishaw, Catherine H. Berlot, Mohsen M. Shabahang, Wannian Yang · 2014 · Oncogene
  34. Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression
    Y-L Hsu, J-Y. Hung, S. H. Chou, M.-Y. Huang, M-J Tsai, Y S Lin, S-Y Chiang, Y-W Ho, C-Y Wu, P-L Kuo · 2014 · Oncogene
  35. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
    Wen Chun Juan, Wanjin Hong · 2016 · Genes
  36. A reciprocal regulatory loop between TAZ/YAP and G-protein Gαs regulates Schwann cell proliferation and myelination
    Yaqi Deng, Lai Man Natalie Wu, Shujun Bai, Chuntao Zhao, Haibo Wang, Jincheng Wang, Lingli Xu, Masahide Sakabe, Wenhao Zhou, Mei Xin et al. · 2017 · Nature Communications
  37. Deregulation of Hippo–TAZ pathway during renal injury confers a fibrotic maladaptive phenotype
    Sandybell Anorga, Jessica M. Overstreet, Lucas L. Falke, Jiaqi Tang, Roel Goldschmeding, Paul J. Higgins, Rohan Samarakoon · 2018 · The FASEB Journal
  38. The Hippo Pathway Regulates Caveolae Expression and Mediates Flow Response via Caveolae
    Valentina Rausch, Jonathan R. Bostrom, Jiwon Park, Isabel Ribeiro Bravo, Yi Feng, David C. Hay, Brian A. Link, Carsten Gram Hansen · 2018 · Current Biology
  39. The Hippo Pathway in Prostate Cancer
    Omar Salem, Carsten Gram Hansen · 2019 · Cells
  40. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy
    Bahar Yetkin-Arik, Arnoud W. Kastelein, Ingeborg Klaassen, Charlotte H. J. R. Jansen, Yani P. Latul, Miloš Vittori, Aydan Bırı, Korhan Kahraman, Arjan W. Griffioen, Frédéric C. Amant et al. · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  41. Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth
    Lu-Shen Li, Runping Fang, Baotang Liu, Hui Shi, Yaming Wang, Wenjing Zhang, Xiaoqing Zhang, L Ye · 2015 · Oncogene
  42. Two distinct trophectoderm lineage stem cells from human pluripotent stem cells
    Adam Mischler, Victoria Karakis, Jessica Mahinthakumar, Celeste K. Carberry, Adriana San‐Miguel, Julia E. Rager, Rebecca C. Fry, Balaji M. Rao · 2021 · Journal of Biological Chemistry
  43. The Hippo pathway in colorectal cancer
    Piotr Wierzbicki, Agnieszka Rybarczyk · 2015 · Folia Histochemica et Cytobiologica
  44. Concerted localization-resets precede YAP-dependent transcription
    John M. Franklin, Rajarshi P. Ghosh, Quanming Shi, Michael P. Reddick, Jan Liphardt · 2020 · Nature Communications
  45. Mechanotransduction at the Plasma Membrane-Cytoskeleton Interface
    Iván P. Uray, Karen Uray · 2021 · International Journal of Molecular Sciences
  46. New insights into the ambivalent role of YAP/TAZ in human cancers
    Juan Luo, Liang Deng, Hailin Zou, Yibo Guo, Tongyu Tong, Mingli Huang, Gengqiang Ling, Peng Li · 2023 · Journal of Experimental & Clinical Cancer Research
  47. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells
    Suowen Xu, Marina Koroleva, Meimei Yin, Zheng Gen Jin · 2016 · Translational research
  48. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis
    Tianxing Zhou, Yongjie Xie, Xupeng Hou, Weiwei Bai, Xueyang Li, Ziyun Liu, Quan Man, Jingyan Sun, Danqi Fu, Jingrui Yan et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  49. The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis
    Miju Kim, Minchul Kim, Mi‐Sun Lee, Cheol‐Hee Kim, Dae‐Sik Lim · 2014 · Nature Communications
  50. Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway
    Gao Liu, Fa‐Xing Yu, Young Chul Kim, Zhipeng Meng, Julián Naipauer, David J. Looney, Xiangguo Liu, Jorge Silvio Gutkind, Enrique A. Mesri, K-L Guan · 2014 · Oncogene
  51. Par‐ aPKC ‐dependent and ‐independent mechanisms cooperatively control cell polarity, Hippo signaling, and cell positioning in 16‐cell stage mouse embryos
    Yoshikazu Hirate, Shino Hirahara, Ken-ichi Inoue, Hiroshi Kiyonari, Hiroshi Niwa, Hiroshi Sasaki · 2015 · Development Growth & Differentiation
  52. Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor
    Ana Sebio, Heinz‐Josef Lenz · 2015 · Clinical Cancer Research
  53. Understanding Membrane Protein Drug Targets in Computational Perspective
    Jianting Gong, Yongbing Chen, Feng Pu, Pingping Sun, Fei He, Li Zhang, Yanwen Li, Zhiqiang Ma, Han Wang · 2018 · Current Drug Targets
  54. CD44 acts through RhoA to regulate YAP signaling
    Yuchen Zhang, Hongwei Xia, Xiaojun Ge, Qingjuan Chen, Dandan Yuan, Qi Chen, Weibing Leng, Liang Chen, Qiulin Tang, Feng Bi · 2014 · Cellular Signalling
  55. Hippo–YAP and mTOR pathways collaborate to regulate organ size
    Alfred Csibi, John Blenis · 2012 · Nature Cell Biology
  56. Hippo-YAP/TAZ signaling in angiogenesis
    Jeong Ae Park, Young‐Guen Kwon · 2018 · BMB Reports
  57. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade
    Ichidai Tanaka, Hiroyuki Osada, Makiko Fujii, A Fukatsu, Toyoaki Hida, Yoshitsugu Horio, Yutaka Kondo, Ayuko Sato, Yoshinori Hasegawa, Tohru Tsujimura et al. · 2013 · Oncogene
  58. Regulation of the Hippo pathway in cancer biology
    Sungho Moon, So Yeon Park, Hyun Woo Park · 2018 · Cellular and Molecular Life Sciences
  59. Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: Implications for vascular function
    Tedy Sawma, Abdullah A. Shaito, Nicolas Najm, Munir Sidani, Alexander Nikolaevich Orekhov, Ahmed Fawzy EL‐Yazbi, Rabah Iratni, Ali Hussein Eid · 2022 · Atherosclerosis
  60. Hippo Pathway in Mammalian Adaptive Immune System
    Takayoshi Yamauchi, Toshiro Moroishi · 2019 · Cells
  61. New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics
    Mingjing He, Zhuan Zhou, Anil A. Shah, Yang Hong, Qianming Chen, Yong Wan · 2016 · Cell Division
  62. YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression
    Huapeng Li, Qi Li, Kyvan Dang, Shan Ma, Jennifer L. Cotton, Sun Yang, Lihua Julie Zhu, APRIL C. DENG, Yicktung Tony Ip, Randy L. Johnson et al. · 2019 · Cell Reports
  63. The Hippo Pathway as a Driver of Select Human Cancers
    Aishwarya Kulkarni, Matthew T. Chang, Joseph H.A. Vissers, Anwesha Dey, Kieran F. Harvey · 2020 · Trends in cancer
  64. The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease
    Zhuo Xie, Ying Wang, Guang Yang, Jing Han, Liguo Zhu, Li Li, Shenghong Zhang · 2021 · Cell Death and Disease
  65. The history and regulatory mechanism of the Hippo pathway
    Wantae Kim, Eek‐hoon Jho · 2018 · BMB Reports
  66. Loss of Mob1a/b in mice results in chondrodysplasia due to YAP1/TAZ-TEAD-dependent repression of SOX9
    Hiroki Goto, Miki Nishio, Yoko To, Tatsuya Oishi, Yosuke Miyachi, Tomohiko Maehama, Hiroshi Nishina, Haruhiko Akiyama, Tak W. Mak, Yuma Makii et al. · 2018 · Development
  67. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis
    Wen-ting Xu, Zhen Yang, C. Xie, Yin Zhu, X. Shu, Zhe Zhang, Nian-Shuang Li, Na Chai, Song Zhang, Kai-Chun Wu et al. · 2018 · Journal of experimental & clinical cancer research : CR
  68. A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis
    Taha Azad, Kazem Nouri, Helena J. Janse van Rensburg, Sarah M. Maritan, Liqing Wu, Yawei Hao, Tess Montminy, Jihang Yu, Prem Khanal, Lois M. Mulligan et al. · 2019 · Oncogene
  69. Secreted stromal protein ISLR promotes intestinal regeneration by suppressing epithelial Hippo signaling
    Jiuzhi Xu, Yang Tang, Xiaole Sheng, Yuhua Tian, Min Deng, Sujuan Du, Cong Lv, Guili Li, Yuwei Pan, Yongli Song et al. · 2020 · The EMBO Journal
  70. YAP activates the Hippo pathway in a negative feedback loop
    Xiaoming Dai, Huan Liu, Shuying Shen, Xiaocan Guo, Huan Yan, Xinyan Ji, Li Li, Jun Huang, Xin‐Hua Feng, Bin Zhao · 2015 · Cell Research
  71. The CalcR-PKA-Yap1 Axis Is Critical for Maintaining Quiescence in Muscle Stem Cells
    Lidan Zhang, Yu-taro Noguchi, Hiroyuki Nakayama, Takayuki Kaji, Kazutake Tsujikawa, Madoka Ikemoto‐Uezumi, Akiyoshi Uezumi, Yoshiaki Okada, Takefumi Doi, Shuichi Watanabe et al. · 2019 · Cell Reports
  72. The Hippo Pathway and Viral Infections
    Zhilong Wang, Wanhang Lu, Yiling Zhang, Feng Zou, Zhigang Jin, Tiejun Zhao · 2020 · Frontiers in Microbiology
  73. PI3K functions as a hub in mechanotransduction
    Mickaël Di‐Luoffo, Zacchari Ben Meriem, Pauline M. Lefebvre, Morgan Delarue, Julie Guillermet‐Guibert · 2021 · Trends in Biochemical Sciences
  74. Cadherin signaling: keeping cells in touch
    Olga Klezovitch, Valeri I. Vasioukhin · 2015 · F1000Research
  75. The Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis
    Eunjeong Seo, Wan‐Young Kim, Jeongmi Hur, Hanbyul Kim, Sun Ah Nam, Arum Choi, Yumi Kim, Sang Hee Park, Chaeuk Chung, Jin Kim et al. · 2016 · Scientific Reports
  76. Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer
    Eleanna Kaffe, Christiana Magkrioti, Vassilis Aidinis · 2019 · Cancers
  77. Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma
    Taohui Ouyang, Wei Meng, Meihua Li, Tao Hong, Na Zhang · 2019 · Cellular and Molecular Neurobiology
  78. YAP and TAZ protect against white adipocyte cell death during obesity
    Lei Wang, Shengpeng Wang, Yue Xi Shi, Rui Li, Stefan Günther, Yu Ting Ong, Michael Potente, Zuyi Yuan, Enqi Liu, Stefan Offermanns · 2020 · Nature Communications
  79. Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling
    Dana J. Ramms, Francesco Raimondi, Nadia Arang, Friedrich W. Herberg, Susan Serota Taylor, Jorge Silvio Gutkind · 2021 · Pharmacological Reviews
  80. A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas
    Michael D. Deel, Jing Li, Lisa E.S. Crose, Corinne Mary Linardic · 2015 · Frontiers in Oncology
  81. HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver
    Bi‐Sen Ding, Catherine H. Liu, Yue Sun, Yutian Chen, Steven L. Swendeman, Bongnam Jung, Deebly Chavez, Zhongwei Cao, Christina Christoffersen, Lars B. Nielsen et al. · 2016 · JCI Insight
  82. Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability
    Youngeun Kim, Wantae Kim, Yonghee Song, Jeong‐Rae Kim, Kyungjoo Cho, Hyuk Moon, Simon Weonsang Ro, Eunjeong Seo, Yeon‐Mi Ryu, Seung‐Jae Myung et al. · 2017 · Proceedings of the National Academy of Sciences
  83. Regulation of follicle growth through hormonal factors and mechanical cues mediated by Hippo signaling pathway
    Ikko Kawashima, Kazuhiro Kawamura · 2017 · Systems Biology in Reproductive Medicine
  84. The Ambivalent Function of YAP in Apoptosis and Cancer
    Xianbin Zhang, Ahmed Abdelrahman, Brigitte Vollmar, Dietmar Zechner · 2018 · International Journal of Molecular Sciences
  85. Hippo Gains Weight: Added Insights and Complexity to Pathway Control
    Leonie Enderle, Helen McNeill · 2013 · Science Signaling
  86. Transcriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53
    Tamara Potapova, Christopher W. Seidel, Andrew Box, Giulia Irene Rancati, Rong Li · 2016 · Molecular Biology of the Cell
  87. Biomechanical relationships between the corneal endothelium and Descemet's membrane
    Maryam Ali, Vijay Krishna Raghunathan, Jennifer Y. Li, Christopher John Murphy, Sara M. Thomasy · 2016 · Experimental Eye Research
  88. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse
    Shu‐Yan Ji, Xiaoman Liu, Bo-Tai Li, Yinli Zhang, Hongbin Liu, Yuchao Zhang, Zi‐Jiang Chen, Junping Liu, Heng‐Yu Fan · 2017 · Molecular Human Reproduction
  89. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation
    Jung‐Chien Cheng, Evan Y. Wang, Yuyin Yi, Avinash Thakur, Shu‐Huei Tsai, Pamela A. Hoodless · 2018 · Molecular Cancer Research
  90. Hippo/YAP pathway for targeted therapy
    Emanuela Felley‐Bosco, Rolf Arno Stahel · 2014 · Europe PMC (PubMed Central)
  91. Loss of VGLL4 suppresses tumor PD‐L1 expression and immune evasion
    Ailing Wu, Qingzhe Wu, Yujie Deng, Yuning Liu, Jinqiu Lu, Liansheng Liu, Xiaoling Li, Cheng Lin Liao, Bin Zhao, Hai Xin Song · 2018 · The EMBO Journal
  92. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer
    Piera Tocci, Roberta Cianfrocca, Valeriana Di Castro, Laura Rosanò, Andrea Sacconi, Sara Donzelli, Silvia Bonfiglio, Gabriele Bucci, Enrico Vizza, Gabriella Ferrandina et al. · 2019 · Nature Communications
  93. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
    Yu-Chen Liu, Xiao-Hui L. Wang, Ying-Zi Yang · 2020 · Clinical and Molecular Hepatology
  94. Evolutionary and Molecular Facts Link the WWC Protein Family to Hippo Signaling
    Dirk Oliver Wennmann, Jürgen Schmitz, Michael C. Wehr, Michael P. Krahn, Nora Koschmal, Sascha Gromnitza, Ulf Schulze, Thomas Weide, Anil K. Chekuri, Boris V. Skryabin et al. · 2014 · Molecular Biology and Evolution
  95. Implications of Nonphysiological Ovarian Primordial Follicle Activation for Fertility Preservation
    Johanne Grosbois, Melody Devos, Isabelle Demeestere · 2020 · Endocrine Reviews
  96. Mechanical Feed-Forward Loops Contribute to Idiopathic Pulmonary Fibrosis
    M.A.T. Freeberg, Apostolos Perelas, Jane K. Rebman, Richard P. Phipps, Thomas H. Thatcher, Patricia J. Sime · 2020 · American Journal Of Pathology
  97. EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1
    Toshinori Ando, Nadia Arang, Zhiyong Wang, Daniela Elena Costea, Xiaodong Feng, Yusuke Goto, Hiroki Izumi, Mara Gilardi, Kazuyo Ando, Jorge Silvio Gutkind · 2021 · Communications Biology
  98. The role of angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development
    Yoshikazu Hirate, Hiroshi Sasaki · 2014 · Tissue Barriers
  99. Actin Cytoskeleton Regulates Hippo Signaling
    Pradeep Reddy, Masashi Deguchi, Yuan Cheng, Aaron J.W. Hsueh · 2013 · PLoS ONE
  100. Hippo pathway in mammary gland development and breast cancer
    Peiguo Shi, Jing Chun Feng, Ceshi Chen · 2014 · Acta Biochimica et Biophysica Sinica